SCHEDULE 13G/A: Investment Firm AIGH Capital Management and Orin Hirschman Disclose 3.6% Stake in TELA Bio, Inc.
Beneficial Ownership Report
AIGH Capital Management LLC and Orin Hirschman have filed an amended Schedule 13G, disclosing a beneficial ownership of 3.6% of TELA Bio, Inc.'s common stock as of March 31, 2025.
Summary
- Orin Hirschman, AIGH Capital Management LLC, and AIGH Investment Partners LLC (collectively, the "Reporting Persons") have filed an Amendment No. 4 to Schedule 13G regarding their beneficial ownership in TELA Bio, Inc.
- As of March 31, 2025, the Reporting Persons collectively beneficially own 1,416,323 shares of TELA Bio, Inc.'s Common Stock.
- This ownership represents 3.6% of the total class of TELA Bio, Inc. Common Stock.
- The Reporting Persons hold sole voting power and sole dispositive power over all 1,416,323 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of TELA Bio, Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or prospects.
Future Outlook
The document is a beneficial ownership report and does not contain any forward-looking statements or guidance regarding TELA Bio, Inc.'s future performance or outlook.
Management Comments
- Orin Hirschman, as a Reporting Person and Managing Member of AIGH Capital Management LLC, certified that, to the best of his knowledge and belief, the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing is a standard disclosure of passive beneficial ownership by an investment firm, indicating a position in TELA Bio, Inc. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The disclosure of a significant, albeit passive, stake by an investment firm like AIGH Capital Management LLC may be viewed by other shareholders as a sign of investor confidence in TELA Bio, Inc.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement |
| 05/08/2025 | Date of filing/signature |
Keywords
TELA Bio Inc., Schedule 13G, Beneficial Ownership, Orin Hirschman, AIGH Capital Management, Common Stock, SEC Filing, Investment Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.